Why did your Market Access VP recently leave? And what’s up with the new one?

Discussion in 'Coherus BioSciences' started by anonymous, Mar 15, 2020 at 10:48 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Outsiders being asked to come inside want to know
     

  2. anonymous

    anonymous Guest

    Colburn is gone?
     
  3. anonymous

    anonymous Guest

    The recruiter M Kim calls all the time

    you have a nam opening in a new part of the country monthly. The new VP is like a car salesman on LinkedIn

    WTF is going on here people
     
  4. anonymous

    anonymous Guest

    Must have hit a nerve. Likely a small peckah. Rumors are false.
     
  5. anonymous

    anonymous Guest

    It’s all smoke and mirrors. As the saying goes, don’t believe the hype. He’s compensating.
     
  6. anonymous

    anonymous Guest

    His peckah is 2 inches. From the ground.
     
  7. anonymous

    anonymous Guest

    Well you lost a other one.

    market access at coherus is complete fraud.

    absolutely no value
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

    What is going on? Coherus is losing business fast. Why? Only 1 GPO partner (ION) and even ION accounts are leaving them. Their contract is not competitive at all. The strategy from CT is just plain stupid. And the sales force is poised to leave them in q4 when RSU's vest. Other than that it's a great place to be.
     
  10. anonymous

    anonymous Guest

    What is wrong with Coherus? Poor strategy. Stated mission is to improve access and decrease cost but strategy is to not be competitive with the other biosimilars and just focus on On Body. Culture is poisonous. Leadership is dishonest. Company structure is not conducive with being competitive on price.